Overview of current scientific studies and publications

The list includes mainly English-language scientific publications that have been published in international journals. However, a few selected German-language articles are also included. The list does not claim to be complete. The RKI and our international experts have selected the publications according to their respective standards. For a better overview, the publications have been grouped into categories, even if some of them also deal with other topics.

In addition, the RKI provides a selection of current publications on epidemiology and public health every month.

Reviews

Long COVID: major findings, mechanisms and recommendations.
Davis HE, McCorkell L, Vogel JM, et al. Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
 
Unexplained post-acute infection syndromes.
Choutka J, Jansari V, Hornig M, et al. Nat Med. 2022 May;28(5):911-923. doi: 10.1038/s41591-022-01810-6. Epub 2022 May 18.
 
Post-COVID Syndrome.
Hallek M, Adorjan K, Behrends U, et al. Dtsch Arztebl Int. 2023 Jan 27;120(4):48-55. doi: 10.3238/arztebl.m2022.0409.
 
Post COVID und Post-Vakzin-Syndrom: Die Pandemie nach der Pandemie.
Scheibenbogen C, Renz-Polster H, Hohberger B, et al. Dtsch Arztebl 2023; 120(13):566-570.

Disease/case definitions

A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus.
World Health Organisation. 2023 Feb 16. 
 
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
Thaweethai T, Jolley SE, Karlson EW, et al. JAMA. 2023 Jun 13;329(22):1934-1946. doi: 10.1001/jama.2023.8823.
 
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
Munblit D, Nicholson T, Akrami A, et al. Lancet Respir Med. 2022 Jul;10(7):715-724. doi: 10.1016/S2213-2600(22)00169-2. Epub 2022 Jun 14.
 
Post-COVID-19 condition in children: a COS is urgently needed.
Munblit D, Buonsenso D, Sigfrid L, et al. Lancet Respir Med. 2022 Jul;10(7):628-629. doi: 10.1016/S2213-2600(22)00211-9. Epub 2022 Jun 14.

Basic research, disease development

Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients.
Thapaliya K, Marshall-Gradisnik S, Barth M, et al. Front Neurosci. 2023 Mar 2;17:1125208. doi: 10.3389/fnins.2023.1125208. 
 
Deficient GABABergic and glutamatergic excitability in the motor cortex of patients with long-COVID and cognitive impairment.
Manganotti P, Michelutti M, Furlanis G, et al. Clin Neurophysiol. 2023 Jul;151:83-91. doi: 10.1016/j.clinph.2023.04.010. 
 
Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI.
Ajčević M, Iscra K, Furlanis G, et al. Sci Rep. 2023 Apr 10;13(1):5808. doi: 10.1038/s41598-023-32275-3.
 
SARS-CoV-2 is associated with changes in brain structure in UK Biobank.
Douaud G, Lee S, Alfaro-Almagro F, et al. Nature. 2022 Apr;604(7907):697-707. doi: 10.1038/s41586-022-04569-5. 
 
Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection.
Schweitzer F, Goereci Y, Franke C, et al. Ann Neurol. 2022 Jan;91(1):150-157. doi: 10.1002/ana.26262. 
 
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
Haffke M, Freitag H, Rudolf G, et al. .J Transl Med. 2022 Mar 22;20(1):138. doi: 10.1186/s12967-022-03346-2.
 
Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro.
Flaskamp L, Roubal C, Uddin S, et al. Cells. 2022 Aug 2;11(15):2376. doi: 10.3390/cells11152376.
 
Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Vernon SD, Funk S, Bateman L, et al. Front Med (Lausanne). 2022 Jun 23;9:917019. doi: 10.3389/fmed.2022.917019. 
 
Coronary microvascular health in symptomatic patients with prior COVID-19 infection: an updated analysis.
Ahmed AI, Al Rifai M, Alahdab F, et al. Eur Heart J Cardiovasc Imaging. 2023 May 31:jead118. doi: 10.1093/ehjci/jead118. 
 
Long-Term Adverse Effects of Mild COVID-19 Disease on Arterial Stiffness, and Systemic and Central Hemodynamics: A Pre-Post Study.
Podrug M, Koren P, Dražić Maras E, et al. .J Clin Med. 2023 Mar 8;12(6):2123. doi: 10.3390/jcm12062123.
 
The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.
Kell DB, Pretorius E.Biochem J. 2022 Aug 31;479(16):1653-1708. doi: 10.1042/BCJ20220154
 
Proteomic profiling demonstrates inflammatory and endotheliopathy signatures associated with impaired cardiopulmonary exercise hemodynamic profile in Post Acute Sequelae of SARS-CoV-2 infection (PASC) syndrome.
Singh I, Leitner BP, Wang Y, et al. Pulm Circ. 2023 Apr 1;13(2):e12220. doi: 10.1002/pul2.12220. 
 
Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response.
Santa Cruz A, Mendes-Frias A, Azarias-da-Silva M, et al. Nat Commun. 2023 Mar 30;14(1):1772. doi: 10.1038/s41467-023-37368-1.
 
Pulmonary Dysfunction after Pediatric COVID-19.
Heiss R, Tan L, Schmidt S, et al. Radiology. 2023 Mar;306(3):e221250. doi: 10.1148/radiol.221250. 
 
Physical phenotype of blood cells is altered in COVID-19.
Kubánková M, Hohberger B, Hoffmanns J, et al. Biophys J. 2021 Jul 20;120(14):2838-2847. doi: 10.1016/j.bpj.2021.05.025. 
 
Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue.
Schlick S, Lucio M, Wallukat G, et al. Int J Mol Sci. 2022 Nov 8;23(22):13683. doi: 10.3390/ijms232213683.
 
The immunology and immunopathology of COVID-19.
Merad M, Blish CA, Sallusto F, et al. Science. 2022 Mar 11;375(6585):1122-1127. doi: 10.1126/science.abm8108.

Symptoms

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
Thaweethai T, Jolley SE, Karlson EW, et al.  JAMA. 2023 Jun 13;329(22):1934-1946. doi: 10.1001/jama.2023.8823.
 
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
Kedor C, Freitag H, Meyer-Arndt L, et al. Nat Commun. 2022 Aug 30;13(1):5104. doi: 10.1038/s41467-022-32507-6.
 
Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onset.
Servier C, Porcher R, Pane I, et al. Int J Infect Dis. 2023 Aug;133:67-74. doi: 10.1016/j.ijid.2023.05.007. 
 
Long-term neurologic outcomes of COVID-19.
Xu E, Xie Y, Al-Aly Z.Nat Med. 2022 Nov;28(11):2406-2415. doi: 10.1038/s41591-022-02001-z. 
 
Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study.
Walker S, Goodfellow H, Pookarnjanamorakot P, et al. BMJ Open. 2023 Jun 7;13(6):e069217. doi: 10.1136/bmjopen-2022-069217.
 
Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study.
Twomey R, DeMars J, Franklin K, et al. Phys Ther. 2022 Apr 1;102(4):pzac005. doi: 10.1093/ptj/pzac005.
 
Cognitive impairment in young adults with post COVID-19 syndrome.
Herrera E, Pérez-Sánchez MDC, San Miguel-Abella R, et al. Sci Rep. 2023 Apr 19;13(1):6378. doi: 10.1038/s41598-023-32939-0.
 
Long-term cardiovascular outcomes of COVID-19.
Xie Y, Xu E, Bowe B, et al. Nat Med. 2022 Mar;28(3):583-590. doi: 10.1038/s41591-022-01689-3. 
 
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks.
Wang W, Wang CY, Wang SI, et al. EClinicalMedicine. 2022 Nov;53:101619. doi: 10.1016/j.eclinm.2022.101619. 
 
Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19.
Malesevic S, Sievi NA, Baumgartner P, et al. Sci Rep. 2023 May 12;13(1):7717. doi: 10.1038/s41598-023-34678-8.
 
Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study.
Wahlgren C, Forsberg G, Divanoglou A, et al. Lancet Reg Health Eur. 2023 May;28:100595. doi: 10.1016/j.lanepe.2023.100595. 

Diagnostics

Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC).
Blitshteyn S, Whiteson JH, Abramoff B, et al. PM R. 2022 Oct;14(10):1270-1291. doi: 10.1002/pmrj.12894. 

Therapy

The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome.
Ghali A, Lacombe V, Ravaiau C, et al. J Transl Med. 2023 Jun 8;21(1):375. doi: 10.1186/s12967-023-04229-w.
 
Rehabilitative interventions in patients with persistent post COVID-19 symptoms-a review of recent advances and future perspectives.
Gloeckl R, Leitl D, Schneeberger T, et al. Eur Arch Psychiatry Clin Neurosci. 2023 Jun 16. doi: 10.1007/s00406-023-01631-9. 
 
Fighting Post-COVID and ME/CFS - development of curative therapies.
Scheibenbogen C, Bellmann-Strobl JT, Heindrich C, et al. Front Med (Lausanne). 2023 Jun 15;10:1194754. doi: 10.3389/fmed.2023.1194754. 
 
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
Bramante CT, Buse JB, Liebovitz DM, et al. Lancet Infect Dis. 2023 Jun 8:S1473-3099(23)00299-2. doi: 10.1016/S1473-3099(23)00299-2. 

ME/CFS

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic.
Bonilla H, Quach TC, Tiwari A, et al. Front Neurol. 2023 Feb 24;14:1090747. doi: 10.3389/fneur.2023.1090747. 
 
Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Campen CLMCV, Rowe PC, Visser FC. Medicina (Kaunas). 2021 Dec 24;58(1):28. doi: 10.3390/medicina58010028.
 
Orthostatic Intolerance in Long-Haul COVID after SARS-CoV-2: A Case-Control Comparison with Post-EBV and Insidious-Onset Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
van Campen CLMC, Visser FC. Healthcare (Basel). 2022 Oct 17;10(10):2058. doi: 10.3390/healthcare10102058.
 
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature.
Komaroff AL, Lipkin WI. Front Med (Lausanne). 2023 Jun 2;10:1187163. doi: 10.3389/fmed.2023.1187163.

Public Health

Long COVID: long-term health outcomes and implications for policy and research.
Al-Aly Z, Agarwal A, Alwan N, et al. Nat Rev Nephrol. 2023 Jan;19(1):1-2. doi: 10.1038/s41581-022-00652-2.
 
Long COVID Through a Public Health Lens: An Umbrella Review.
Nittas V, Gao M, West EA, et al. Public Health Rev. 2022 Mar 15;43:1604501. doi: 10.3389/phrs.2022.1604501. 
 
Long COVID – eine Herausforderung für Public Health und Gesundheitsforschung. 
Nübel J, Sarganas G, Mikolajewska A, et al:. Epid Bull 2022; 44:3-9. doi: 10.25646/10753 
 
Healthcare use in 700 000 children and adolescents for six months after covid-19: before and after register based cohort study.
Magnusson K, Skyrud KD, Suren P, et al. BMJ. 2022 Jan 17;376:e066809. doi: 10.1136/bmj-2021-066809.
 
Long-Term Effects of COVID-19 on Workers in Health and Social Services in Germany.
Peters C, Dulon M, Westermann C, et al. Int J Environ Res Public Health. 2022 Jun 7;19(12):6983. doi: 10.3390/ijerph19126983.
 
Gesundheitsreport 2022 – Zwei Jahre Coronapandemie: Wie geht es Deutschlands Beschäftigten? Techniker Krankenkasse (TK). (2022). Teil 2. 2022 Jul. Verfügbar unter: https://www.tk.de 
 
Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
Honigsbaum M, Krishnan L. Lancet. 2020 Oct 31;396(10260):1389-1391. doi: 10.1016/S0140-6736(20)32134-6. 
 
Über 60 Prozent der Patient:innen mit Post-COVID-19-Diagnose nur in einem Quartal in vertragsärztlicher Behandlung.
Monitor Versorgungsforschung. 2022 Apr 24.
 
Krankschreibungen aufgrund von Long-COVID: Wenige Betroffene, aber lange krankheitsbedingte Ausfallzeiten
Willenborg, P. idw – Informationsdienst Wissenschaft. 2022 Sep 14. Verfügbar unter: idw-online.de/de/news801167

Protection/risk factors

Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis.
Tsampasian V, Elghazaly H, Chattopadhyay R, et al. JAMA Intern Med. 2023 Jun 1;183(6):566-580. doi: 10.1001/jamainternmed.2023.0750.
 
Prevalence of long COVID decreases for increasing COVID-19 vaccine uptake.
De Domenico M. PLOS Glob Public Health. 2023 Jun 21;3(6):e0001917. doi: 10.1371/journal.pgph.0001917. 
 
Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong.
Luo J, Zhang J, Tang HT, et al. J Med Virol. 2023 Jun;95(6):e28862. doi: 10.1002/jmv.28862.
 
Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants.
Wang C, Ramasamy A, Verduzco-Gutierrez M, Brode WM, Melamed E. Virol J. 2023 Jun 16;20(1):124. doi: 10.1186/s12985-023-02061-8.
 
Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort.
Shi Y, Strobl R, Apfelbacher C, et al. Infection. 2023 May 25:1-16. doi: 10.1007/s15010-023-02043-6. Online ahead of print.
 
Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.
Morello R, Mariani F, Mastrantoni L, et al. EClinicalMedicine. 2023 May;59:101961. doi: 10.1016/j.eclinm.2023.101961. 
 
Post-acute sequelae after SARS-CoV-2 infection by viral variant and vaccination status: a multicenter cross-sectional study.
Kahlert CR, Strahm C, Güsewell S, et al. Clin Infect Dis. 2023 Mar 11:ciad143. doi: 10.1093/cid/ciad143. Online ahead of print.
 
Effect of covid-19 vaccination on long covid: systematic review.
Byambasuren O, Stehlik P, Clark J, et al. BMJ Med. 2023 Feb 1;2(1):e000385. doi: 10.1136/bmjmed-2022-000385. 
 
Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
Ballouz T, Menges D, Kaufmann M, et al. PLoS One. 2023 Feb 22;18(2):e0281429. doi: 10.1371/journal.pone.0281429. 
 
Factors Associated With Long COVID Symptoms in an Online Cohort Study.
Durstenfeld MS, Peluso MJ, Peyser ND, et al. Open Forum Infect Dis. 2023 Feb 1;10(2):ofad047. doi: 10.1093/ofid/ofad047. 
 
Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants.
Magnusson K, Kristoffersen DT, Dell'Isola A, et al. Nat Commun. 2022 Nov 30;13(1):7363. doi: 10.1038/s41467-022-35240-2.
 
Symptoms and risk factors for long COVID in non-hospitalized adults.
Subramanian A, Nirantharakumar K, Hughes S, et al. Nat Med. 2022 Aug;28(8):1706-1714. doi: 10.1038/s41591-022-01909-w. 
 
Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review.
Notarte KI, Catahay JA, Velasco JV, et al. EClinicalMedicine. 2022 Aug 27;53:101624. doi: 10.1016/j.eclinm.2022.101624.
 
Multiple early factors anticipate post-acute COVID-19 sequelae.
Su Y, Yuan D, Chen DG, et al. Cell. 2022 Mar 3;185(5):881-895.e20. doi: 10.1016/j.cell.2022.01.014. 
 
Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis.
Notarte KI, de Oliveira MHS, Peligro PJ, et al. J Clin Med. 2022 Dec 9;11(24):7314. doi: 10.3390/jcm11247314.
 
Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
Robineau O, Zins M, Touvier M, et al. JAMA Netw Open. 2022 Nov 1;5(11):e2240985. doi: 10.1001/jamanetworkopen.2022.40985.
 
Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis.
Gao P, Liu J, Liu M. Int J Environ Res Public Health. 2022 Sep 29;19(19):12422. doi: 10.3390/ijerph191912422.
 
Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID).
Pazukhina E, Andreeva M, Spiridonova E, et al. BMC Med. 2022 Jul 6;20(1):244. doi: 10.1186/s12916-022-02448-4.
 
Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records.
Thompson EJ, Williams DM, Walker AJ, et al. Nat Commun. 2022 Jun 28;13(1):3528. doi: 10.1038/s41467-022-30836-0.

Prevalence, incidence

How common is long COVID? Why studies give different answers.
Ledford H. Nature. 2022 Jun;606(7916):852-853. doi: 10.1038/d41586-022-01702-2.
 
One-Year Temporal Changes in Long COVID Prevalence and Characteristics: A Systematic Review and Meta-Analysis.
Huang Q, Jia M, Sun Y, et al. Value Health. 2023 Jun;26(6):934-942. doi: 10.1016/j.jval.2022.11.011. 

Prevalence of long COVID complaints in persons with and without COVID-19.
Magnusson K, Turkiewicz A, Flottorp SA, et al. Sci Rep. 2023 Apr 13;13(1):6074. doi: 10.1038/s41598-023-32636-y.
 
Post-COVID-19 condition in the German working population: A cross-sectional study of 200,000 registered stem cell donors.
Bernas SN, Baldauf H, Real R, et al. J Intern Med. 2023 Mar;293(3):354-370. doi: 10.1111/joim.13587. 
 
Pooled Prevalence of Long COVID-19 Symptoms at 12 Months and Above Follow-Up Period: A Systematic Review and Meta-Analysis.
Mudgal SK, Gaur R, Rulaniya S, et al. Cureus. 2023 Mar 18;15(3):e36325. doi: 10.7759/cureus.36325. 
 
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK.
Office for National Statistics (ONS). 2023 Mar 30. Verfügbar unter: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023
 
The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis.
O'Mahoney LL, Routen A, Gillies C, et.al. EClinicalMedicine. 2022 Dec 1;55:101762. doi: 10.1016/j.eclinm.2022.101762. 
 
Prevalence and clinical presentation of long COVID in children: a systematic review.
Pellegrino R, Chiappini E, Licari A, et al. Eur J Pediatr. 2022 Dec;181(12):3995-4009. doi: 10.1007/s00431-022-04600-x. Epub 2022 Sep 15.
 
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.
Chen C, Haupert SR, Zimmermann L, et al. J Infect Dis. 2022 Nov 1;226(9):1593-1607. doi: 10.1093/infdis/jiac136.
 
A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents.
Dumont R, Richard V, Lorthe E, et al. 2022 Nov 29;13(1):7086. doi: 10.1038/s41467-022-34616-8.
 
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
Global Burden of Disease Long COVID Collaborators; Wulf Hanson S, Abbafati C, Aerts JG et al. JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931.
 
Prevalence of post COVID-19 condition symptoms: a systematic review and meta-analysis of cohort study data, stratified by recruitment setting
European Centre for Disease Prevention and Control (ECDC). 2022 Oct 31. Verfügbar unter: https://www.ecdc.europa.eu/en/publications-data/prevalence-post-covid-19-condition-symptoms-systematic-review-and-meta-analysis
 
Post-COVID-19 conditions in children and adolescents diagnosed with COVID-19.
Kostev K, Smith L, Koyanagi A, et al. Pediatr Res. 2022 May 14:1-6. doi: 10.1038/s41390-022-02111-x. Online ahead of print. 

Epidemiology and public health 

Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study.
Ballouz T, Menges D, Anagnostopoulos A, et al. BMJ. 2023 May 31;381:e074425. doi: 10.1136/bmj-2022-074425.
 
A Systematic Review of Persistent Clinical Features After SARS-CoV-2 in the Pediatric Population.
Jiang L, Li X, Nie J, et al. 2023 Jul 21:e2022060351. doi: 10.1542/peds.2022-060351. Online ahead of print.
 
Understanding How Post-COVID-19 Condition Affects Adults and Health Care Systems.
Katz GM, Bach K, Bobos P, et al. JAMA Health Forum. 2023 Jul 7;4(7):e231933. doi: 10.1001/jamahealthforum.2023.1933.
 
SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis.
Kelly et al. Eur Respir Rev. 2023 Jul 12;32(169):220254. doi: 10.1183/16000617.0254-2022. Print 2023 Sep 30.
 
Post-COVID Conditions.
Mueller MR, Ganesh R, Hurt RT, et al. Mayo Clin Proc. 2023 Jul;98(7):1071-1078. doi: 10.1016/j.mayocp.2023.04.007.
 
Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations.
Parotto M, Gyöngyösi M, Howe K, et al. Lancet Respir Med. 2023 Jul 17:S2213-2600(23)00239-4. doi: 10.1016/S2213-2600(23)00239-4. Online ahead of print.
 
New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis.
Rahmati M, Yon DK, Lee SW, et al. J Med Virol. 2023 Jul;95(7):e28909. doi: 10.1002/jmv.28909.
 
Long COVID in Children: A Multidisciplinary Review.
Sansone F, Pellegrino GM, Caronni A, et al. Diagnostics (Basel). 2023 Jun 7;13(12):1990. doi: 10.3390/diagnostics13121990.
 
Neuropsychological deficits in patients with persistent COVID-19 symptoms: a systematic review and meta-analysis.
Sobrino-Relaño S, Balboa-Bandeira Y, Peña J, et al. Sci Rep. 2023 Jun 26;13(1):10309. doi: 10.1038/s41598-023-37420-6.
 
A scoping review of persistent symptoms after COVID infection at different follow-up periods.
Sreelakshmi PR, Tandale BV, Jadhav AV, et al. Indian J Public Health. 2023 Apr-Jun;67(2):292-300. doi: 10.4103/ijph.ijph_1178_22.

Postacute sequelae of COVID-19 at 2 years.
Bowe B, Xie Y, Al-Aly Z.Nat Med. 2023 Sep;29(9):2347-2357. doi: 10.1038/s41591-023-02521-2. Epub 2023 Aug 21. 

Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients.  
Di Gennaro F, Belati A, Tulone O, et al. Intern Emerg Med. 2023 Aug;18(5):1573-1581. doi: 10.1007/s11739-022-03164-w. Epub 2022 Nov 30. 

Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.
Heidemann C, Sarganas G, Du Y, et al. BMC Public Health. 2023 Aug 21;23(1):1587. doi: 10.1186/s12889-023-16524-8. 

Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis. 
Kuodi P, Gorelik Y, Gausi B, et al. Int J Infect Dis. 2023 Sep;134:1-7. doi: 10.1016/j.ijid.2023.05.003. Epub 2023 May 6. 

Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort. 
Legler F, Meyer-Arndt L, Mödl L, et al. EClinicalMedicine. 2023 Aug 19;63:102146. doi: 10.1016/j.eclinm.2023.102146. eCollection 2023 Sep. 

Symptom Profiles of Children and Young People 12 Months after SARS-CoV-2 Testing: A National Matched Cohort Study (The CLoCk Study). 
Pinto Pereira SM, Nugawela MD, McOwat K, et al. Children (Basel). 2023 Jul 14;10(7):1227. doi: 10.3390/children10071227.

S1 guidelines for the management of postviral conditions using the example of post-COVID-19.
Rabady S, Hoffmann K, Aigner M, et al. Wien Klin Wochenschr. 2023 Jul;135(Suppl 4):525-598. doi: 10.1007/s00508-023-02242-z. Epub 2023 Aug 9. 

Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update. 
Su S, Zhao Y, Zeng N, et al. Mol Psychiatry. 2023 Jul 25. doi: 10.1038/s41380-023-02171-3. Online ahead of print.

15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.    
Augustin M, Stecher M, Wüstenberg H, et al. Front Immunol. 2023 Sep 12;14:1226622. doi: 10.3389/fimmu.2023.1226622. eCollection 2023.    
    
True prevalence of long COVID in children: a narrative review.    
Esposito S, Deolmi M, Ramundo G, et al. 2023 Sep 14;14:1225952. doi: 10.3389/fmicb.2023.1225952. eCollection 2023.    
    
Impact of COVID-19 critical illness on functional status, fatigue symptoms, and health-related quality of life one-year after hospital discharge: a systematic review and meta-analysis.    
Gesser AF, Campos ML, Artismo RS, et al. 2023 Oct 11:1-12. doi: 10.1080/09638288.2023.2266365. Online ahead of print.    
    
Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study.    
Hill EL, Mehta HB, Sharma S, et al. BMC Public Health. 2023 Oct 25;23(1):2103. doi: 10.1186/s12889-023-16916-w.    
    
Post COVID sequelae among COVID-19 survivors: insights from the Indian National Clinical Registry for COVID-19.    
Kumar G, Bhalla A, Mukherjee A, et al. BMJ Glob Health. 2023 Oct;8(10):e012245. doi: 10.1136/bmjgh-2023-012245.    
    
Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis     
Luo D, Mei B, Wang P, et al. Clin Microbiol Infect. 2023 Oct 20:S1198-743X(23)00526-8. doi: 10.1016/j.cmi.2023.10.016. Online ahead of print.    
    
Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review.    
Müller SA, Isaaka L, Mumm R, et al. Lancet Glob Health. 2023 Nov;11(11):e1713-e1724. doi: 10.1016/S2214-109X(23)00384-4.   

Long-term health impacts of COVID-19 among 242,712 adults in England.           
Atchison CJ, Davies B, Cooper E, et al. Nat Commun. 2023 Oct 24;14(1):6588. doi: 10.1038/s41467-023-41879-2.      

Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study.    
Gorst SL, Seylanova N, Dodd SR, et al.; PC-COS study group.Lancet Respir Med. 2023 Dec;11(12):1101-1114. doi: 10.1016/S2213-2600(23)00370-3. Epub 2023 Nov 2.    

Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.   
Mateu L, Tebe C, Loste C, et al. Lancet Reg Health Eur. 2023 Sep 5;33:100724. doi: 10.1016/j.lanepe.2023.100724. eCollection 2023 Oct.  

What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection.  
Nicotra A, Masserini F, Calcaterra F, et al. Eur J Neurol. 2023 Dec;30(12):3968-3978. doi: 10.1111/ene.16027. Epub 2023 Aug 26.  

Clinical Characterization of the Persistent COVID-19 Symptoms: A Descriptive Observational Study in Primary Care.  
Rodríguez Onieva A, Vallejo Basurte C, Fernández Bersabé A, et al. J Prim Care Community Health. 2023 Jan-Dec;14:21501319231208283. doi: 10.1177/21501319231208283.  

Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité Fatigue Center. 
Steiner S, Fehrer A, Hoheisel F, et al. Autoimmun Rev. 2023 Nov;22(11):103452. doi: 10.1016/j.autrev.2023.103452. Epub 2023 Sep 22.

Allergic diseases as risk factors for Long-COVID symptoms: Systematic review of prospective cohort studies. 
Wolff D, Drewitz KP, Ulrich A, et al. Clin Exp Allergy. 2023 Nov;53(11):1162-1176. doi: 10.1111/cea.14391. Epub 2023 Nov 8.

Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A systematic review and meta-analysis.    
Hoshijima H, Mihara T, Seki H, et al. PLoS One. 2023 Nov 29;18(11):e0250909. doi: 10.1371/journal.pone.0250909. eCollection 2023    

The effect of the urban exposome on COVID-19 health outcomes: A systematic review and meta-analysis. 
Houweling L, Maitland-Van der Zee AH, Holtjer JCS, et al. Environ Res. 2024 Jan 1;240(Pt 2):117351. doi: 10.1016/j.envres.2023.117351. Epub 2023 Oct 17   

Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study.  
Lundberg-Morris L, Leach S, Xu Y, et al. BMJ. 2023 Nov 22;383:e076990. doi: 10.1136/bmj-2023-076990.

The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research.  
Marra AR, Kobayashi T, Callado GY, et al. Antimicrob Steward Healthc Epidemiol. 2023 Oct 13;3(1):e168. doi: 10.1017/ash.2023.447. eCollection 2023.  

Association Between Duration of SARS-CoV-2 Positivity and Long COVID.  
Pozzi C, Sarti R, Levi R, et al. Clin Infect Dis. 2023 Nov 30;77(11):1531-1533. doi: 10.1093/cid/ciad434. 

Risk factors for long COVID in children and adolescents: a systematic review and meta-analysis.  
Rayner DG, Wang E, Su C, et al. World J Pediatr. 2023 Oct 27. doi: 10.1007/s12519-023-00765-z. Online ahead of print.

The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults.  
Azzam A, Khaled H, Refaey N, et al. Virol J. 2024 Jan 11;21(1):16. doi: 10.1186/s12985-024-02284-3.  

Post-COVID health policy responses to healthcare workforce capacities: A comparative analysis of health system resilience in six European countries.  
Burau V, Mejsner SB, Falkenbach M, et al. Health Policy. 2024 Jan;139:104962. doi: 10.1016/j.healthpol.2023.104962. Epub 2023 Dec 13.  

The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia.  
Català M, Mercadé-Besora N, Kolde R, et al. Lancet Respir Med. 2024 Jan 11:S2213-2600(23)00414-9. doi: 10.1016/S2213-2600(23)00414-9. Online ahead of print. 

Serological markers and long COVID – A rapid systematic review. 
Collins E, Philippe E, Gravel CA, et al. Eur J Clin Invest. 2023 Dec 11:e14149. doi: 10.1111/eci.14149. Online ahead of print. 

Epidemiology of 7375 children and adolescents hospitalized with COVID-19 in Germany, reported via a prospective, nationwide surveillance study in 2020-2022. 
Doenhardt M, Hufnagel M, Diffloth N, et al. Sci Rep. 2024 Jan 2;14(1):47. doi: 10.1038/s41598-023-49210-1. 

Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden. 
Fedorowski A, Fanciulli A, Raj SR, et al. Nat Rev Cardiol. 2024 Jan 2. doi: 10.1038/s41569-023-00962-3. Online ahead of print. 

Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis. 
Fernandez-de-Las-Peñas C, Notarte KI, Macasaet R, et al. J Infect. 2024 Feb;88(2):77-88. doi: 10.1016/j.jinf.2023.12.004. Epub 2023 Dec 13. 

Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions. 
Fernández-de-Las-Peñas C, Raveendran AV, Giordano R, et al. Microorganisms. 2023 Dec 11;11(12):2959. doi: 10.3390/microorganisms11122959. 

Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. 
Fernández-de-Las-Peñas C, Torres-Macho J, Catahay JA, et al.  Infection. 2024 Feb;52(1):43-58. doi: 10.1007/s15010-023-02154-0. Epub 2023 Dec 19. 

Applicability of heart rate variability for cardiac autonomic assessment in long-term COVID patients: A systematic review. 
Ferreira ÁA, Abreu RM, Teixeira RS, et al. J Electrocardiol. 2024 Jan-Feb;82:89-99. doi: 10.1016/j.jelectrocard.2023.12.002. Epub 2023 Dec 12. 

Incidence and burden of long COVID in Africa: a systematic review and meta-analysis. 
Frallonardo L, Segala FV, Chhaganlal KD, et al. Sci Rep. 2023 Dec 6;13(1):21482. doi: 10.1038/s41598-023-48258-3. 

Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020-2022. 
Marra AR, Sampaio VS, Ozahata MC, et al. Infect Control Hosp Epidemiol. 2023 Dec;44(12):1972-1978. doi: 10.1017/ice.2023.95. Epub 2023 Jun 5. 

Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ). 
Peo LC, Wiehler K, Paulick J, et al. Eur J Pediatr. 2023 Dec 14. doi: 10.1007/s00431-023-05351-z. Online ahead of print. 

Correction: Prevalence of mental health problems among children with long COVID: A systematic review and meta-analysis. 
PLOS ONE Staff. PLoS One. 2023 Dec 14;18(12):e0296160. doi: 10.1371/journal.pone.0296160. eCollection 2023. 

Vaccine Effectiveness Against Long COVID in Children. 
Razzaghi H, Forrest CB, Hirabayashi K, et al. Pediatrics. 2024 Jan 16. Doi: 10.1542/peds.2023-064446. Online ahead of print. 

Long-Term Effects of COVID-19 on the Cardiopulmonary System in Adults and Children: Current Status and Questions to be Resolved by the National Institutes of Health Researching COVID to Enhance Recovery Initiative. 
Rischard F, Altman N, Szmuszkovicz J, et al. Chest. 2024 Jan 6:S0012-3692(24)00006-0. Doi: 10.1016/j.chest.2023.12.030. Online ahead of print. 

Return to work after Post-COVID: describing affected employees' perceptions of personal resources, organizational offerings and care pathways. 
Straßburger C, Hieber D, Karthan M, et al. Front Public Health. 2023 Nov 27;11:1282507. Doi: 10.3389/fpubh.2023.1282507. eCollection 2023. 

Looking at the Data on Smoking and Post-COVID-19 Syndrome – A Literature Review. 
Trofor AC, Robu Popa D, Melinte OE, et al. J Pers Med. 2024 Jan 16;14(1):97. Doi: 10.3390/jpm14010097. 

Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review. 
Yang J, Markus K, Andersen KM, et al. BMJ Open. 2024 Jan 17;14(1):e077886. Doi: 10.1136/bmjopen-2023-077886. 

Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. 
Xie Y, Choi T, Al-Aly Z. Lancet Infect Dis. 2023 Dec 14:S1473-3099(23)00684-9. Doi: 10.1016/S1473-3099(23)00684-9. Online ahead of print. 

Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis. 
Yamamoto S, Matsuda K, Maeda K, et al. J Infect Dis. 2023 Dec 20 ;228(12) :1652-1661. Doi : 10.1093/infdis/jiad317. 

Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study. 
Zhao S, Martin EM, Reuken PA, et al. EClinicalMedicine. 2024 Jan 25;68:102434. doi: 10.1016/j.eclinm.2024.102434. eCollection 2024 Feb. 

Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data.  
Bello-Chavolla OY, Fermín-Martínez CA, Ramírez-García D, et al. Lancet Reg Health Am. 2024 Feb 3;30:100688. doi: 10.1016/j.lana.2024.100688. eCollection 2024 Feb.  

Cognitive domains affected post-COVID-19; a systematic review and meta-analysis.  
Fanshawe JB, Sargent BF, Badenoch JB, et al. Eur J Neurol. 2024 Feb 20:e16181. doi: 10.1111/ene.16181. Online ahead of print.  

Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies. 
Franco JVA, Garegnani LI, Metzendorf MI, et al. BMJ Med. 2024 Jan 29;3(1):e000723. doi: 10.1136/bmjmed-2023-000723. eCollection 2024. 

Prevalence and trajectories of post-COVID-19 neurological manifestations: A systematic-review and meta-analysis. 
Giussani G, Westenberg E, Garcia-Azorin D, et al. Neuroepidemiology. 2024 Jan 25. doi: 10.1159/000536352. Online ahead of print. 

Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study. 
Gorst SL, Seylanova N, Dodd SR, et al. Lancet Respir Med. 2023 Dec;11(12):1101-1114. doi: 10.1016/S2213-2600(23)00370-3. Epub 2023 Nov 2. 

Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. 
Greene C, Connolly R, Brennan D, et al. Nat Neurosci. 2024 Feb 22. doi: 10.1038/s41593-024-01576-9. Online ahead of print. 

Vaccination and the risk of post-acute sequelae after COVID-19 in the Omicron-predominant period. 
Huh K, Kim YE, Bae GH, et al. Clin Microbiol Infect. 2024 Feb 6:S1198-743X(24)00054-5. doi: 10.1016/j.cmi.2024.01.028. Online ahead of print. 

Social Inequalities in Long-Term Health Effects After COVID-19 – A Scoping Review. 
Lammers N, Beese F, Hoebel J, et al. Int J Public Health. 2024 Feb 7; 69:1606739. doi: 10.3389/ijph.2024.1606739. eCollection 2024. 

Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies. 
Makovski TT, Ghattas J, Monnier-Besnard S, et al. Aging Clin Exp Res. 2024 Feb 14;36(1):40. doi: 10.1007/s40520-023-02685-4. 

SARS-CoV-2 Infection and Risk of Postacute Psychiatric and Neurologic Diagnoses: A Nationwide Danish Cohort Study. 
Nielsen NM, Spiliopoulos L, Hansen JV, et al. Neurology. 2024 Mar 12;102(5):e208113. doi: 10.1212/WNL.0000000000208113. Epub 2024 Feb 21. 

Association of psychiatric disorders with clinical diagnosis of long COVID in US veterans. 
Nishimi K, Neylan TC, Bertenthal D, et al. Psychol Med. 2024 Feb 5:1-9. doi: 10.1017/S0033291724000114. Online ahead of print. 

Navigating the Spectrum of Two Pediatric COVID-19 Complications: Multi-System Inflammatory Syndrome in Children and Post-Acute Sequelae of SARS-CoV-2 Infection. 
Parzen-Johnson S, Katz BZ. J Clin Med. 2024 Feb 18;13(4):1147. doi: 10.3390/jcm13041147. 

Association of vaccine status, reinfections, and risk factors with Long COVID syndrome. 
Romero-Ibarguengoitia ME, Rodríguez-Torres JF, Garza-Silva A, et al. Sci Rep. 2024 Feb 2;14(1):2817. doi: 10.1038/s41598-024-52925-4. 

The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis. 
Seighali N, Abdollahi A, Shafiee A, et al. BMC Psychiatry. 2024 Feb 6;24(1):105. doi: 10.1186/s12888-023-05481-6. 

Core Outcome Measurement Set for Research and Clinical Practice in Post COVID-19 Condition (Long COVID) in Children and Young People: An International Delphi Consensus Study "PC-COS Children". 
Seylanova N, Chernyavskaya A, Degtyareva N, et al. Eur Respir J. 2024 Feb 15:2301761. doi: 10.1183/13993003.01761-2023. Online ahead of print. 

Long COVID in pediatrics-epidemiology, diagnosis, and management. 
Toepfner N, Brinkmann F, Augustin S, et al. Eur J Pediatr. 2024 Jan 27. doi: 10.1007/s00431-023-05360-y. Online ahead of print. 

Cardiovascular disease as part of Long COVID: A systematic review. 
Tsampasian V, Bäck M, Bernardi M, et al. Eur J Prev Cardiol. 2024 Feb 21:zwae070. doi: 10.1093/eurjpc/zwae070. Online ahead of print. 

Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study. 
Yendewa GA, Perez JA, Patil N, McComsey GA. Front Immunol. 2024 Jan 22;15:1297195. doi: 10.3389/fimmu.2024.1297195. eCollection 2024. 

Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies. 
Annesley SJ, Missailidis D, Heng B, et al. Trends Mol Med. 2024 Mar 4:S1471-4914(24)00028-5. doi: 10.1016/j.molmed.2024.02.003. Online ahead of print. 

What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence. 
Cruickshank M, Brazzelli M, Manson P, et al .PLoS One. 2024 Mar 5;19(3):e0299743. doi: 10.1371/journal.pone.0299743. eCollection 2024. 

Developing effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population- The need for caution and objective assessment. 
Faghy MA, Duncan R, Hume E, et al. Prog Cardiovasc Dis. 2024 Mar 8:S0033-0620(24)00039-2. doi: 10.1016/j.pcad.2024.03.003. Online ahead of print. 

Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry. 
Leone MA, Helbok R, Bianchi E, et al. J Neurol. 2024 Mar 4. doi: 10.1007/s00415-024-12212-8. Online ahead of print. 

IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS). 
Preßler H, Machule ML, Ufer F, et al. Trials. 2024 Mar 7;25(1):172. doi: 10.1186/s13063-024-07982-5. 

Postacute Sequelae of SARS-CoV-2 in Children. 
Rao S, Gross RS, Mohandas S, et al. Pediatrics. 2024 Mar 1;153(3):e2023062570. doi: 10.1542/peds.2023-062570. 

Unmasking the long-term effects: unravelling neuropsychiatric and neurological consequences of COVID-19. 
Tariq M, Mahak F, Kumar R, et al. Ann Med Surg (Lond). 2024 Jan 4;86(3):1490-1495. doi: 10.1097/MS9.0000000000001624. eCollection 2024 Mar. 

Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis. 
van der Feltz-Cornelis C, Turk F, Sweetman J, et al. Gen Hosp Psychiatry. 2024 Feb 27;88:10-22. doi: 10.1016/j.genhosppsych.2024.02.009. Online ahead of print.  

Using a data-driven approach to define post-COVID conditions in US electronic health record data.  
Andersen KM, Khan FL, Park PW, et al. PLoS One. 2024 Apr 5;19(4):e0300570. doi: 10.1371/journal.pone.0300570. eCollection 2024.  

A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2.  
Bedran D, Bedran G, Kote S.Vaccines (Basel). 2024 Feb 21;12(3):222. doi: 10.3390/vaccines12030222.  

UK biobank: Enhanced assessment of the epidemiology and long-term impact of coronavirus disease-2019.  
Feng Q, Lacey B, Bešević J, et al. Camb Prism Precis Med. 2023 Aug 29;1:e30. doi: 10.1017/pcm.2023.18. eCollection 2023.  

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches.  
Gheorghita R, Soldanescu I, Lobiuc A, et al. 2024 Mar 4;15:1344086. doi: 10.3389/fimmu.2024.1344086. eCollection 2024.  

Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis.  
Giussani G, Westenberg E, Garcia-Azorin D, et al.; Global COVID-19 Neuro Research Coalition.Neuroepidemiology. 2024;58(2):120-133. doi: 10.1159/000536352. Epub 2024 Jan 25.  

Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway.  
Iversen A, Blomberg B, Haug K, et al. Front Public Health. 2024 Mar 5;12:1320059. doi: 10.3389/fpubh.2024.1320059. eCollection 2024.  

Long COVID's Impact on Patients, Workers, & Society: A review.  
Kavanagh KT, Cormier LE, Pontus C, et al. Medicine (Baltimore). 2024 Mar 22;103(12):e37502. doi: 10.1097/MD.0000000000037502.  

Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis.  
Kitsios GD, Blacka S, Jacobs JJ, et al. BMJ Open. 2024 Mar 14;14(3):e077869. doi: 10.1136/bmjopen-2023-077869.  

Cross-sectional population-based estimates of a rural-urban disparity in prevalence of long COVID among Michigan adults with polymerase chain reaction-confirmed COVID-19, 2020-2022.  
MacCallum-Bridges CL, Hirschtick JL, Allgood KL, et al. 2024 Mar;40(2):303-313. doi: 10.1111/jrh.12807. Epub 2023 Nov 16.  

The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020-2022.  
MacCallum-Bridges C, Hirschtick JL, Patel A, et al. Epidemiol. 2024 Apr;92:17-24. doi: 10.1016/j.annepidem.2024.02.007. Epub 2024 Feb 19.  

Gender differences in symptomatology, socio-demographic information and quality of life in Spanish population with long COVID condition: a cross-sectional study.  
Marcilla-Toribio I, Moratalla-Cebrián ML, Notario-Pacheco B, et al. Front Public Health. 2024 Mar 21;12:1355973. doi: 10.3389/fpubh.2024.1355973. eCollection 2024.  

Vaccine Effectiveness Against Long COVID in Children.  
Razzaghi H, Forrest CB, Hirabayashi K, Wu Q, Allen AJ, et al. RECOVER CONSORTIUM. Pediatrics. 2024 Apr 1;153(4):e2023064446. doi: 10.1542/peds.2023-064446.  

Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates.  
Saheb Sharif-Askari F, Ali Hussain Alsayed H, Saheb Sharif-Askari N, et al. Public Health. 2024 May;230:198-206. doi: 10.1016/j.puhe.2024.02.031. Epub 2024 Apr 3.  

Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID.  
Seo JW, Kim SE, Kim Y, et al. Infect Chemother. 2024 Mar; 56(1):122-157. doi: 10.3947/ic.2024.0024. Epub 2024 Mar 13.  

From Acute Infection to Prolonged Health Consequences: Understanding Health Disparities and Economic Implications in Long COVID Worldwide.  
Sweis JJG, Alnaimat F, Esparza V, et al.Int J Environ Res Public Health. 2024 Mar 11;21(3):325. doi: 10.3390/ijerph21030325.  

Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.  
Woldegiorgis M, Cadby G, Ngeh S, et al. Med J Aust. 2024 Apr 1;220(6):323-330. doi: 10.5694/mja2.52256. Epub 2024 Mar 20.